The Third Annual PMO Live Conference, a Global Biomarkers Consortium Initiative, opened today with a record turnout. More than 100 registrants were welcomed by Dr. Roy Herbst, Chief of Medical Oncology at the Yale Comprehensive Cancer Center, one of the Congress co-chairs. Dr. Herbst provided an overview of the exciting new developments in the molecular pathophysiology and personalized therapy of cancer, and laid out the goals of the meeting.

View Digital Edition